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Abstract
Background: Presently available flow cytometric methods of bromodeoxyuridine (BrdUrd) labelling do
not provide information on the cell cycle time (TC) and the growth fraction (GF). In this paper, we describe
a novel and simple method to estimate TC and GF from flow cytometric analysis of a single tumour sample
after BrdUrd labelling.
Methods: The proposed method is based on two assumptions: (1) the number of labelled cells traversing
the cell cycle per unit time is constant and (2) the total number of labelled cells is constant throughout the
cycle, provided that cells produced after division are excluded. The total numbers of labelled divided G1
cells, labelled divided S cells, labelled undivided S cells, and labelled undivided G2 cells were obtained for
DNA histograms of BrdUrd-positive cells in a collected sample. These cell numbers were used to write
equations to determine the durations of cell cycle phases, TC and GF. To illustrate the application of the
proposed formulae, cell cycle kinetic parameters were analysed in solid SL2 tumours growing in DBA/2
mice and in human T-leukaemia Jurkat cells in culture.
Results: The suitability of the proposed method for estimating durations of the cell cycle phases, TC and
GF was demonstrated. TC in SL2 tumours was found to be relatively constant at 4 and 10 days after tumour
implantation (20.3 ± 1.1 h and 21.6 ± 0.9 h, respectively). GF in tumours at day 10 was lower than GF at
day 4 (54.2 ± 7.7% vs. 79.2 ± 5.9%, p = 0.0003). Approximate values of TC and GF of cultured Jurkat cells
were 23.9 h and 79.3%, respectively.
Conclusion:  The proposed method is relatively simple and permits estimation of the cell cycle
parameters, including TC and GF, from a single tumour sample after labelling with BrdUrd. We have shown
that this method may be useful in preclinical studies, allowing estimation of changes in GF during growth
of murine tumours. Experiments with human Jurkat cells suggest that the proposed method might also
prove suitable for measurement of cell kinetics in human tumours. Development of suitable software
enabling more objective interpretation of the DNA profile in this method would be desirable.
Published: 22 September 2005
BMC Cancer 2005, 5:122 doi:10.1186/1471-2407-5-122
Received: 28 December 2004
Accepted: 22 September 2005
This article is available from: http://www.biomedcentral.com/1471-2407/5/122
© 2005 Eidukevicius et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Cancer 2005, 5:122 http://www.biomedcentral.com/1471-2407/5/122
Page 2 of 11
(page number not for citation purposes)
Background
Uncontrolled proliferation is regarded as one of the most
important traits of malignancy. Therefore, a considerable
effort has been directed to the evaluation of the parame-
ters of cell kinetics in tumours. A significant improvement
in cell kinetic studies was achieved by the introduction of
the technique of flow cytometric analysis of cells labelled
with bromodeoxyuridine (BrdUrd) and the relative move-
ment (RM) method [1]. The RM method allows estima-
tion of the duration of S phase (TS) and the labelling index
(LI) from a single sample. From these parameters, the
potential doubling time (Tpot) can be calculated. Tpot is
defined as the time to double the number of proliferating
cells in the absence of cell loss [1]. This derived cell kinetic
parameter has been postulated to be a predictor of a
tumour's proliferative capability and has been widely
studied in clinic in an attempt to find its prognostic signif-
icance and the potential value in predicting treatment out-
come [2]. However, more recent evidence has not
confirmed the existence of association between Tpot and
disease outcome measures, whereas information on clini-
cal significance of LI and TS remains ambiguous [3-5].
Therefore, new methods of evaluating cell kinetics in
tumours are required.
Cell production rate is determined by the cell cycle time
(TC), i.e. the time interval between cell divisions, and the
growth fraction (GF), i.e. the proportion of cells engaged
in the cell cycle. Thus, TC and GF can be regarded as the
most important parameters in evaluating cell production
in tumours. However, neither the original RM method [1]
nor its more recent modification [6] provide enough data
to calculate the duration of all cell cycle phases, conse-
quently the duration of the whole cycle, and GF of a
tumour.
TC and GF can be estimated by calculating the percent
BrdUrd labelling in tumour samples vs. time after injec-
tion of BrdUrd. However, the disadvantage of this method
is that subsequent tumour samples have to be taken at
intervals during several days after the administration of
BrdUrd [7]. This method does not allow a measurement
of cell kinetics in an individual tumour at a particular time
point and is useless in a clinical setting.
Currently, proliferation-related antigen Ki-67 is widely
used to measure GF in tumours and normal tissues. The
Ki-67 antigen is considered to be present in the nuclei of
cells in the G1, S and G2 phases of the cell cycle as well as
in mitosis, but not in quiescent cells (cells in G0) [8].
Although the relationship between Ki-67 protein expres-
sion and cell proliferation is established, there is some evi-
dence that expression of Ki-67 antigen may be minimal in
late G1 and early S phase cells [9]. The accessibility of Ki-
67 epitopes may vary during the cell cycle [10]. In addi-
tion, not all cells containing Ki-67 antigen may be actively
proliferating [11]. Thus, detection of proliferative markers
(such as Ki-67) may not correspond in every case to the
theoretically defined term of GF. Obviously, determina-
tion of proliferative markers does not provide informa-
tion about TC.
In this paper, we describe a novel and simple method to
estimate TC and GF from flow cytometric analysis of a sin-
gle tumour sample after BrdUrd labelling.
Methods
Mice and tumours
Female DBA/2 mice at the age of 8–12 weeks were
obtained from the local breeding facility at the Institute of
Immunology, Vilnius, Lithuania. SL2, a spontaneously
arisen DBA/2 – derived lymphoma was maintained by
weekly intraperitoneal passage in DBA/2 mice. Solid SL2
tumours for cell proliferation analysis were induced by
subcutaneous injection of 107 SL2 cells on the chest of
mice and analysed after 4 and 10 days.
Experimental research on animals has been conducted
according to recommendations of the Lithuanian Ethics
Committee for the Laboratory Animal Use.
Cell culture
Human acute T-cell leukaemia Jurkat cells were cultured
in RPMI 1640 medium supplemented with 10% foetal
bovine serum. The cultures were incubated at 37°C in a
humidified atmosphere with 5% CO2.
BrdUrd labelling
The mice were injected i.p. with 1 ml of 2 mg/ml BrdUrd
(5-bromo-2'-deoxyuridine, Sigma, St Louis, MO, USA)
solution in physiological saline. The half-life of BrdUrd in
rodent blood is only about 15 min. Therefore, a single i.p.
injection acts as a pulse label [12]. At 10 h after BrdUrd
injection the tumours were dissected and cut into slices of
about 1 mm thickness. To avoid sampling errors, several
slices were cut both from central and peripheral parts of a
tumour. Tumour slices were fixed in 70% ethanol, and
stored at +4°C for one or two days until staining.
For in vitro labelling of Jurkat cells, BrdUrd was dissolved
in phosphate-buffered saline (PBS) and added to culture
medium at a final concentration of 10 µM. After incuba-
tion for 30 min at 37°C, the cells were rinsed twice with
RPMI 1640 medium and the cultures further incubated at
37°C. Samples for analysis were taken at 8, 10, 12 and 16
h after the BrdUrd pulse, the cells were washed with PBS
and fixed in 70% ice-cold ethanol.BMC Cancer 2005, 5:122 http://www.biomedcentral.com/1471-2407/5/122
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Flow cytometric staining and measurement
Slices of solid SL2 tumours were cut in fragments of about
1 mm3 and incubated in 0.4 mg/ml pepsin solution in 0.1
N HCl at 37°C with continuous agitation to produce a
nuclear suspension. Isolation of nuclei was revealed by
microscopic observation after 30 to 60 min of incubation.
The nuclear suspension was filtered through a 48 µm
nylon mesh. Nuclear suspensions of SL2 cells and suspen-
sions of fixed Jurkat cells were washed and incubated in 2
N HCl for 30 min at room temperature for DNA denatur-
ation. The acid solution was then neutralised with 0.1 M
Na2B4O7 (pH 8.5) and the nuclear or cell suspensions
were washed twice in PBS. Fifty µl of PBS containing 0.5%
Tween 20 and 20 µl of FITC-conjugated mouse anti-
BrdUrd monoclonal antibody (Becton Dickinson, Heidel-
berg, Germany) was added to the pellet containing 106
nuclei and incubated for 30 min at room temperature in
the dark. After washing twice in PBS, 1 ml of a solution
containing 5 mg/l propidium iodide (Sigma, St Louis,
MO, USA) in PBS was added to the pellet and incubated
for 30 min at 37°C in the dark.
The cellular DNA content and the amount of incorporated
BrdUrd were simultaneously measured using a FACSort
flow cytometer (Becton Dickinson, Heidelberg, Ger-
many). Green fluorescent light emission (FITC = BrdUrd
incorporation) was collected in the FL1 detector and red
fluorescence (propidium iodide = DNA content) was col-
lected in FL2 (for SL2 cells) or FL3 (for Jurkat cells) detec-
tor. Data from 15,000 nuclei per sample were acquired as
dot plots of BrdUrd labelling vs. DNA content using
LYSYS II software (Becton Dickinson, Heidelberg, Ger-
many). Doublets were excluded by using the doublet dis-
crimination mode. WinMDI version 2.8 software was
used to analyse the acquired data.
Mathematical formulae for estimation of duration of cell 
cycle phases and GF in BrdUrd-labelled tumours
We propose that the total number of cells Sl labelled dur-
ing the BrdUrd pulse can be estimated after any time inter-
val shorter than the duration of the cell cycle as
where Slu – labelled undivided S cells, G2
lu – labelled undi-
vided G2 cells, G1
ld – labelled divided G1 cells, and Sld –
labelled divided S cells (1/2 is introduced to exclude cells
produced after division). Theoretical DNA distributions
of BrdUrd-labelled cells at different post-labelling times
are graphically represented in Figure 1. The equation (1)
is based on the assumption that labelled cell mortality or
exit from the cell cycle during the period of measurement
is negligible. If this is the case, the total number of cells
labelled during the BrdUrd pulse remains constant
throughout the cycle, provided that cells produced after
division are excluded. Mitotic cells are not included in the
analysis, since they lack the nuclear membrane and the
cell membrane is disrupted by the nuclear isolation
medium used for preparation for flow cytometric analysis
[13]. Taking into account that the mitotic time is relatively
short and the number of cells in mitosis can be regarded
as negligible, the omission of mitotic cells may not have a
considerable impact on estimation of the total number of
BrdUrd-labelled cells.
Dot plots of BrdUrd labelling vs. DNA content were used
to gate BrdUrd-positive cells (Figure 2A). The gate settings
were adjusted on the control profiles, so as reproducibly
to distinguish BrdUrd-positive fluorescence. G1
ld, Sld, Slu
and G2
lu  compartments in each DNA histogram of
BrdUrd-positive cells were determined manually and
numbers of cells in each of these compartments were
obtained using statistics option of WinMDI 2.8 software
(Figure 2B). These cell numbers were used in the equa-
tions of the proposed method. Instead of cell numbers,
cell percentages over the total number of cells measured
per sample can also be used.
The proposed method requires that considerable propor-
tions of cells be found in Slu and Sld compartments. Slu and
Sld compartments can be distinguished in the DNA histo-
gram of BrdUrd-positive cells, provided that the time
interval t after the BrdUrd pulse is shorter than the dura-
tion of the S phase, but sufficient for the labelled cells to
re-enter a new S phase, i.e. if   +   < t < TS (,  
and TS are durations of G2, G1 and S phases of the cell
cycle, respectively). Sld compartment was separated from
Slu compartment by the channel corresponding to the
lowest number of events (Figure 2C).
The number of labelled cells traversing S phase per unit
time can be estimated as
The number of labelled cells traversing G2 phase, mitosis,
G1 phase and re-entering S phase per unit time can be esti-
mated as
The labelled cells begin to enter G1 phase after time 
and the number of cells traversing G1 phase and re-enter-
ing S phase per unit time can be estimated as
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The labelled cells begin to re-enter S phase after time 
+   and the number of cells re-entering S phase per unit
time can be estimated as
Estimation of durations of cell cycle phases in the pro-
posed method is based on the assumption that the
number of labelled cells traversing the cell cycle per unit
time is constant. One of the models illustrating this
assumption is the rectangular age distribution of prolifer-
ating cells described by Steel [14]. In this case, ν1 = ν2 = ν3
= ν4 and
The equation (1) and sequentially the equalities of the
equation (6) can be used to determine TS,   and :
Theoretical DNA distributions of BrdUrd-labelled cells vs. cell number at different post-labelling times Figure 1
Theoretical DNA distributions of BrdUrd-labelled cells vs. cell number at different post-labelling times. A – 
immediately after BrdUrd pulse, i.e. at t = 0, B – at 0 < t < , C – at   < t < TS and   < t <  +  , and D – at 
 +   < t < TS. ,  TS and   are durations of G1, S and G2 phases of the cell cycle, respectively. Horizontal lines 
dividing G1
ld and Sld bars indicate that half of the labelled divided cells are excluded from calculations.
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GF can be estimated using the classical formula reported
by Steel [14]:
where LI is the labelling index of the whole population
and LIP is the labelling index of proliferating cells. If the
number of labelled cells traversing the cell cycle per unit
time is constant, we have
where TC is the duration of the cell cycle (TC =   +  TS +
). The LI can be calculated by the formula proposed
by Johansson et al. [13]:
where nt  is the total number of BrdUrd-positive and
BrdUrd-negative cells measured per sample, G2 is the total
number of G2  phase cells and G2
ul is the number of
unlabelled G2 cells. In the proposed method, t < TS and
G2
ul is negligible. Thus, the total number of G2 phase cells
is approximately equal to G2
lu.
Formulae for estimation of durations of cell cycle phases
based on a decreasing exponential cell age distribution
hypothesis are presented in the Additional file 1.
RM approach
In addition to using the proposed formulae, TS values
were estimated also using the classical RM method [1],
here referred to as RM (linear), and the more recently pro-
posed RM method, based on a cubic fit to the RM [6], here
referred to as RM (cubic). The latter method also allows
calculation of  . Using the RM (linear) method, the
relative mean DNA content RM(t) of the moving cohort of
BrdUrd-labelled cells in relation to that of G1 and G2 cells,
was calculated using the formula
Example of estimation of SL2 tumour cell numbers within dif- ferent compartments of the cell cycle 10 h after in vivo label- ling with BrdUrd Figure 2
Example of estimation of SL2 tumour cell numbers 
within different compartments of the cell cycle 10 h 
after in vivo labelling with BrdUrd. A. Flow cytometric 
dual parameter dot plot of BrdUrd content (log FITC fluo-
rescence) vs. DNA content (propidium iodide fluorescence) 
with a gate set for BrdUrd positive cells. B. DNA histogram 
analysis of BrdUrd positive cells; M1 indicates labelled divided 
G1 cells (G1
ld); M2 indicates labelled divided S cells (Sld); M3 
indicates labelled undivided S cells (Slu); M4 indicates labelled 
undivided G2 cells (G2
lu). C. The same DNA histogram as in 
B, shown at higher magnification; Sld compartment is sepa-
rated from Slu compartment by the channel corresponding to 
the lowest number of events (indicated by dotted vertical 
line). Total number of cells within each of these markers is 
obtained using statistics option of WinMDI 2.8 software.
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where   and   are the mean DNA content of cells in
G1 and G2 phases, respectively, FLU is the mean DNA con-
tent of labelled undivided cells (Slu and G2
lu) and t is post-
labelling time. TS was calculated from the equation
Using the RM (cubic) method, TS was calculated from the
equation
In this equation, ν is defined as
where flu(t) and fld(t) are fractions of labelled undivided
and labelled divided cells, respectively, at post-labelling
time t. In our case, flu(t) is the fraction of Slu and G2
lu cells,
and fld(t) – the fraction of G1
ld and Sld cells, respectively,
in the total number of cells nt measured per sample.
An assumed exponential growth rate c was estimated as
where
 was calculated from the equation
 = t + ln(1 - fld(t)/2)/c   (19)
Statistics
Pearson's correlation coefficient was used to determine
the correlation between the TS or   values obtained
using the proposed method and the RM approach. Differ-
ences between the GF values at day 4 and day 10 were ana-
lysed by the Wilcoxon rank sums test.
Results
To illustrate application of the proposed formulae, dura-
tion of cell cycle phases and GF were analysed in solid SL2
tumours at 4 and 10 days after implantation.  , TS, 
and TC values estimated using the proposed method and
TS and   values in the same tumours estimated using
the RM approach are given in Table 1. A significantly pos-
itive correlation between the TS values obtained using the
proposed method and the RM approach was observed
(Figures 3A and 3B). In addition, a significantly positive
correlation was observed between the   values
obtained with the proposed method and with the RM
(cubic) method (Figure C).
GF in solid SL2 tumours at 4 days and 10 days after
implantation, estimated using the proposed method, are
shown in Figure 4. GF in solid SL2 tumours at 10 days was
significantly lower than GF at 4 days after implantation.
Representative dot plots of BrdUrd content vs. DNA con-
tent of Jurkat cells at different post-labelling times are
shown in Figure 5. Samples of Jurkat cells taken at 8 h after
the BrdUrd pulse were not suitable for analysis with the
proposed method, because there were no labelled cells in
the Sld compartment, i.e. the labelled cells had not yet
entered the new S phase. Interval of 12 h appeared to be
the most appropriate for cell kinetic analysis of Jurkat cells
with the proposed method, because there were considera-
ble proportions of cells both in the Sld compartment and
in the Slu compartment. At 10 h, the number of labelled
cells in the Sld compartment was still rather low, whereas
at 16 h, only the small number of cells remained in the Slu
compartment. Estimates of cell cycle phases and GF in Jur-
kat cell line obtained at 10 h, 12 h and 16 h after BrdUrd
labelling are presented in Table 2.
Estimates of durations of cell cycle phases based on rec-
tangular age distribution hypothesis and corresponding
estimates obtained by calculations based on a decreasing
exponential cell age distribution hypothesis are compared
in supplementary Table 1 [see Additional file 1]. Numeri-
cal examples illustrating that the estimates of durations of
cell cycle phases are not very sensitive to erroneous setting
(+/-5%) of regions of interest in the DNA-BrdUrd plots
are presented in supplementary Table 2 [see Additional
file 2].
Discussion
The proposed method is based on two assumptions. The
first assumption, i.e., the labelled cell mortality or exit
from the cell cycle during the period of measurement is
negligible, can be regarded as reasonably simple and gen-
erally acceptable. On the other hand, it is quite difficult to
obtain reliable estimates of cell death rates in bivariate
BrdUrd/DNA cytometry. A method for estimating the rate
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of cell death in G2/M phase of exponentially growing cell
populations has only recently been published [15].
The second assumption is that the number of labelled
cells traversing the cell cycle per unit time is constant.
Although rather simplistic, this assumption does not
appear to induce a great extent of error, as illustrated by
corresponding estimates obtained by calculations based
on a decreasing exponential cell age distribution
hypothesis.
Our results illustrate, that the proposed method can be
successfully used to obtain kinetic estimates of the cell
cycle and GF in a murine tumour in vivo and in human
tumour cells in vitro. The finding of a decrease in GF with
the "age" of murine tumours shows that information
retrieved with the proposed method may be biologically
relevant. A good correlation was found between the TS val-
ues of SL2 tumours obtained using our proposed method
and the generally accepted RM (linear) or RM (cubic)
methods. The   values of SL2 tumours obtained with
the proposed method correlated with the   values
obtained with the RM (cubic) method.
The TS values obtained with the proposed method had a
narrower spread (11.6 to 14.7 h) compared to the TS val-
ues in the same tumours obtained with the RM (linear)
and the RM (cubic) method (12.6 to 17.6 h and 13.5 to
18.9 h, respectively). Thus, the TS values of SL2 tumours
obtained with the proposed method are more compatible
with the notion that TS may be a species-specific constant
[16]. The TS values obtained using the proposed method
were slightly lower than those obtained using the RM
methods. This difference can be explained by the fact that
in the RM approach, the moving cohort of BrdUrd-
labelled cells includes some G2 cells, which actually are
not moving in the histogram. Thus, the RM of the cohort
of BrdUrd-labelled cells is slower than actual traversing of
cells through the S phase. Therefore, we think that our
proposed formulae provide more accurate estimation of
TS.
Similarly to other methods of analysis of cell kinetics
using DNA profiles, the proposed method is subject to
errors of profile interpretation. Using a fitting programme
to extract more accurate data would be preferable. To our
knowledge, however, currently available fitting pro-
grammes (including ModFit LT™, version 3.1) do not
allow the separation of Slu and Sld compartments, the
essential procedure in the proposed method. Thus, none
of the currently available software can by applied for anal-
ysis of the DNA profile in a way required for the proposed
method. On the other hand, the identification of a single
channel with the minimum event count to separate Slu
and Sld compartments was feasible in all DNA histograms
analysed and, therefore, can be regarded as quite robust
procedure.
Table 1: Estimation of durations of cell cycle phases in murine SL2 tumours using the proposed method and the RM methods *
Tumour "age" Method TG1 TS TG2 TC
4 days (n = 10) Proposed 5.1 ± 0.4 12.6 ± 1.0 2.6 ± 0.5 20.3 ± 1.1
RM (linear) N.A. 14.1 ± 1.5 N.A. N.A.
RM (cubic) N.A. 14.8 ± 1.6 0.7 ± 0.4 N.A.
10 days (n = 9) Proposed 5.4 ± 0.5 12.9 ± 0.6 3.3 ± 0.5 21.6 ± 0.9
RM (linear) N.A. 14.4 ± 1.1 N.A. N.A.
RM (cubic) N.A. 15.8 ± 3.3 1.4 ± 0.6 N.A.
* Values are given in h (mean ± SD)
N.A. = not available
Table 2: Estimation of durations of cell cycle phases and GF in Jurkat cell line using the proposed method at different times of 
measurement *
Hours after BrdUrd 
labelling
TG1 TS TG2 TC GF (%)
10 5.2 11.1 4.7 21.0 78.9
12 9.3 12.2 2.4 23.9 79.3
16 14.2 16.3 1.0 31.5 53.3
* Values obtained from individual measurements, given in h
TG2
TG2BMC Cancer 2005, 5:122 http://www.biomedcentral.com/1471-2407/5/122
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Both the RM approach and the proposed method entail
the problem of separation of diploid tumour cells from
normal intratumoural cells. In the proposed method,
admixture of normal cells does not affect the determina-
tion of TC, because this parameter is estimated using only
BrdUrd-labelled cells, and proliferation of normal intratu-
moural cells is usually negligible. However, the proposed
method may underestimate GF in diploid tumours, if pro-
cedures to separate normal cells from tumour cells are not
used. The possible solutions to tackle this problem have
been summarized by Antognoni P et al. [2] and are mainly
based on using cytokeratin markers to separate epithelial
tumour cells from intratumoural inflammatory cells and
fibroblasts. In addition, it is recommended to present cell
kinetic data from diploid and aneuploid tumours sepa-
rately [17]. SL2 was proved to be an aneuploid (nearly
tetraploid) tumour with the DNA index of 1.8 (data not
shown). Thus, admixture of normal cells in our analysis
can be ruled out.
In experiments with SL2 tumour, PI fluorescence was col-
lected in the FL2 detector and compensation for the spec-
tral overlap with FITC fluorescence was used. Generally,
however, it is recommended to use FL3 (as done in exper-
iments with Jurkat cells) rather than FL2 to overcome any
crossover with the FITC in FL1 [12]. Running the samples
Correlation between cell cycle phase duration values  obtained with the proposed method and with the RM  approach for mouse solid SL2 tumours Figure 3
Correlation between cell cycle phase duration values 
obtained with the proposed method and with the RM 
approach for mouse solid SL2 tumours. A. Correlation 
between TS values obtained with the proposed method and 
with the RM (linear) method. B. Correlation between TS val-
ues obtained with the proposed method and with the RM 
(cubic) method. C. Correlation between   values 
obtained with the proposed method and with the RM (cubic) 
method.
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GF in solid SL2 tumours at 4 days and at 10 days 
after tumour implantation (mean ± SD). The difference 
between GF at day 4 and day 10 is statistically significant (p = 
0.0003).
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at a higher FL3 voltage such that more of the scale is used
would facilitate detection of hypodiploid DNA peaks.
In the RM approach, BrdUrd is injected usually 4 to 8 h
prior to biopsy or surgical removal of a tumour [18]. The
proposed method requires that considerable proportions
of cells be found in each of the four compartments to be
analysed (Slu, G2
lu, G1
ld, and Sld). This condition is ful-
filled only if the time interval from the BrdUrd pulse to
the time of measurement is longer than duration of G2
and G1 phases but still shorter than duration of S phase.
Obviously, this cannot be assured in advance. Thus, the
proposed method has to be tailored for a particular
tumour type and the optimal time of measurement has to
be found by trial and error. As an example of this trial and
error procedure, the finding of an optimal time for meas-
urement of cell kinetics in Jurkat cells is described in this
paper.
Measurements with Jurkat cells also show, that the pro-
posed method may be sensitive to intercell variability in
phase transit times. If the time of measurement is too
Representative dot plots of BrdUrd content (log FITC fluorescence) vs. DNA content (propidium iodide fluorescence) of Jur- kat cells at different post-labelling times Figure 5
Representative dot plots of BrdUrd content (log FITC fluorescence) vs. DNA content (propidium iodide fluo-
rescence) of Jurkat cells at different post-labelling times. Jurkat tumour cells were labelled with BrdUrd for 30 min and 
then fixed after 8 h (A), 10 h (B), 12 h (C) and 16 h (D). A. Labelled cells have not yet entered the Sld compartment. B. Labelled 
cells start entering the Sld compartment. C. Considerable proportions of labelled cells are present both in the Sld and in the Slu 
compartment. D. Labelled cells are leaving the Slu compartment. The optimal time for measurement of cell kinetics in Jurkat 
cells with the proposed method appears to be 12 h.
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short and only the fastest cells enter Sld compartment (e.g.
10 h in case of Jurkat cells), the duration of G1 phase may
be underestimated. On the other hand, if the time of
measurement is too long and only the slowest cells
remain in the Slu compartment (e.g. 16 h in case of Jurkat
cells), the duration of S and other cell cycle phases may be
overestimated. Thus, the time for measurement of cell
kinetics with the proposed method has to be selected care-
fully. To minimize the effect of intercell variability in
phase transit times, it is advisable to use the same time
interval from the BrdUrd pulse to the time of measure-
ment in all samples to be compared.
Measurements with cultured Jurkat cells presented in this
paper suggest that the proposed method might be also
suitable for studies on human tumours. It seems that the
suitability of the proposed method for clinical studies
could only be compromised if the G1 phase in human
tumours in vivo was very long. Obviously, this can only be
determined by testing the proposed method in clinical
studies after infusion of BrdUrd to patients.
Conclusion
The proposed method is relatively simple and permits
estimation of cell cycle parameters, including TC and GF,
from a single tumour sample after labelling with BrdUrd.
We have shown that this method may be useful in preclin-
ical studies, allowing estimation of changes in GF during
growth of murine tumours. Experiments with human Jur-
kat cells suggest that the proposed method might also
prove suitable for measurement of cell kinetics in human
tumours. Development of suitable software enabling
more objective interpretation of the DNA profile in this
method would be desirable.
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